In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other stocks. The stock market extended its winning streak on Wednesday, closing firmer as investors ...

GSK (GSK), a large British drug maker, is rallying 8% after reporting higher-than-expected fourth-quarter earnings per share and raising its long-term revenue guidance. Last quarter, its operating ...

Q4 2024 dividend of 16p declared; 61p FY 2024; 64p expected for 2025. GSK (GSK) now intends to commence a GBP 2B share buyback programme, to be implemented over the next 18 months. Published first ...

In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price target of £14.40. The company’s shares opened today ...

GSK said it now e American depositary shares of GSK jumped more than 8% Wednesday after the drugmaker reported better-than-expected quarterly results and boosted its long-term sales forecast.

Who would've thought that a child's toy would've been the inspiration for the name of the greatest spectacle in professional sports? It's safe to say that not even Lamar Hunt, the man who is ...

The 2025 AT&T Pebble Beach Pro-Am may be the second signature event on the PGA Tour's calendar, but it will be the first which features some of the biggest names in the sport. With a total of 80 ...

Caitlin Clark is already one of the faces of the WNBA at 23 years old, and she will soon have a signature Nike shoe and logo to match the fanfare surrounding her. Nike CEO Elliott Hill told Devin ...

GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines. The University of Oxford and GSK are to work on a vaccine to target cells in the ...

"We had Caitlin Clark today," Hill told Fortune. "... We're working on her signature shoe that will launch, and we're working on her logo and that design." Hill did not say when Clark's shoe or ...